In this webinar, Dr. Alfredo Hidalgo Miranda will demonstrate the potential and flexibility of Oxford Nanopore Technologies’ sequencing platforms in cancer and infectious disease research. He will ...

Oxford Nanopore sequencing overcomes these challenges, providing scientists and public health officials with a comprehensive, rapid, and cost-effective pathogen surveillance approach. A long-term ...

OXFORD, England, April 14, 2025--(BUSINESS WIRE)--Oxford Nanopore Technologies today announced the expansion of its Compatible Products Programme (CPP), welcoming a new cohort of leading partners ...

Oxford Nanopore Technologies has teamed up with Cepheid to speed up infectious disease genomic analysis, blocking out recent noise of acquisition vulnerability. The UK biotech, a former star of ...

An Oxford biotech company has announced a new cohort of leading partners. Oxford Nanopore Technologies, which develops and sells nanopore sequencing products, has announced the expansion of its ...

Oxford Nanopore Technologies PLC ( (GB:ONT)) just unveiled an update. Oxford Nanopore Technologies PLC announced a transaction involving its Share Incentive Plan (SIP) where Nick Keher, ...

"Combining the ease-of-use of the GeneXpert system, the most widely placed PCR diagnostic instrument world-wide, with Oxford Nanopore's unique sequencing platform, unlocks a richness of biomarker ...

LONDON - Oxford Nanopore Technologies plc (LSE: ONT), a pioneer in nanopore-based molecular sensing technology, and Cepheid, a major player in molecular diagnostics, announced today a strategic ...

Oxford Nanopore Technologies today announced the expansion of its Compatible Products Programme (CPP), welcoming a new cohort of leading partners whose products now integrate seamlessly with ...